CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer.
Gutiontov SI, Turchan WT, Spurr LF, Rouhani SJ, Chervin CS, Steinhardt G, Lager AM, Wanjari P, Malik R, Connell PP, Chmura SJ, Juloori A, Hoffman PC, Ferguson MK, Donington JS, Patel JD, Vokes EE, Weichselbaum RR, Bestvina CM, Segal JP, Pitroda SP.
Gutiontov SI, et al. Among authors: juloori a.
Sci Rep. 2021 Oct 8;11(1):20059. doi: 10.1038/s41598-021-99524-1.
Sci Rep. 2021.
PMID: 34625620
Free PMC article.